PROMAKHOS THERAPEUTICS
Promakhos Therapeutics is building a platform of bacterial molecules to awaken the human body’s innate ability to control inflammation and heal.
PROMAKHOS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2021-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.promakhos.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
125 K USD
Technology used in webpage:
Amazon YouTube Twitter Tweet Button Google Identity Platform Facebook Like Button Google Plus One Button
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investors List
Asymmetry Ventures
Asymmetry Ventures investment in Seed Round - Promakhos Therapeutics
Pioneer Fund
Pioneer Fund investment in Seed Round - Promakhos Therapeutics
Founders, Inc.
Founders, Inc. investment in Seed Round - Promakhos Therapeutics
Ethan Oren Perlstein
Ethan Oren Perlstein investment in Seed Round - Promakhos Therapeutics
PROTOCOL — by GETTYLAB
PROTOCOL — by GETTYLAB investment in Pre Seed Round - Promakhos Therapeutics
Y Combinator
Y Combinator investment in Pre Seed Round - Promakhos Therapeutics
Allston Venture Fund
Allston Venture Fund investment in Pre Seed Round - Promakhos Therapeutics
Official Site Inspections
http://www.promakhos.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Promakhos Therapeutics"
Promakhos Therapeutics
Promakhos Therapeutics is incredibly honored to share that the company has been awarded the Propel a Cure for Crohn's Disease research award for 2024! Propel a Cure is an all-volunteer …See details»
Promakhos Therapeutics - Crunchbase Company …
Promakhos Therapeutics closed its last funding round on Sep 2, 2021 from a Seed round. Who are Promakhos Therapeutics 's competitors? Alternatives …See details»
Promakhos Therapeutics - LinkedIn
Promakhos Therapeutics | 549 followers on LinkedIn. Creating transformative medicines for patients with inflammatory diseases. | Developing transformative medicines for patients with …See details»
Promakhos Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Promakhos Therapeutics Inc. of Somerville, MA. Get the latest business insights from Dun & Bradstreet.See details»
Promakhos Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 2, 2021: Seed Round - …See details»
Promakhos Therapeutics - Y Combinator
I founded Promakhos because I think we have given to “autoimmune” diseases a grossly misleading name and we treat them in a primitive way. Promakhos means the first to enter a …See details»
Promakhos Therapeutics
Katerina Chatzi is a co-founder and the Chief Executive Officer and President of Promakhos Therapeutics. Katerina is a distinguished scientist-entrepreneur with expertise in immunology, …See details»
Promakhos Therapeutics - VentureRadar
Promakhos Therapeutics is developing new drugs for inflammatory disorders. Current therapies are immunosuppressive, do not work very well, often require injection and can cause …See details»
Promakhos Therapeutics, Inc. - Drug pipelines, Patents, Clinical …
Explore Promakhos Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Meet Promakhos Therapeutics | 2024 Harvard President's
May 16, 2024 Promakhos Therapeutics is developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.Learn more about Promakhos: https://...See details»
Promakhos Therapeutics
Promakhos Therapeutics is excited to announce that it has been selected to engage with Morrison & Foerster LLP through their selective and exclusive emerging growth company program. …See details»
Promakhos Therapeutics - Contacts, Employees, Board Members, …
Promakhos Therapeutics provides a therapeutics platform for curing inflammatory disorders. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Promakhos Therapeutics - PitchBook
Promakhos Therapeutics General Information Description. Developer of immunotherapies designed for the treatment of inflammatory diseases. The company has developed modulators …See details»
Promakhos Therapeutics - BIO International Convention | BIO
Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... At …See details»
Promakhos Therapeutics - Harvard Innovation Labs
Promakhos Therapeutics is developing cures for autoimmune diseases. Millions of people suffer from autoimmunity, yet there is currently no cure. Existing treatments focus on blocking the …See details»
Promakhos Therapeutics - VentureRadar
Promakhos Therapeutics is developing new drugs for inflammatory disorders. Current therapies are immunosuppressive, do not work very well, often require injection and can cause …See details»
Promakhos Therapeutics
Promakhos Therapeutics welcomes Dr. Joshua Korzenik and Dr. Jean-Frédéric Colombel to the scientific advisory board ... and Chair of the International Organization for the Study of …See details»
Promakhos Therapeutics
Promakhos Therapeutics has closed its first round of financing after participating in the summer 2021 batch of Y Combinator, a Silicon Valley accelerator. The newly raised funds will be used …See details»
Promakhos Therapeutics
Promakhos Therapeutics is developing new drugs for inflammatory disorders. Current therapies are immunosuppressive, do not work very well, often require injection and can cause …See details»
Promakhos Therapeutics
Promakhos Therapeutics is excited to announce that its scientists have been selected to join the Harvard Pagliuca Life Lab for Spring 2021, with the option to extend its stay through an official …See details»